Replies to post #5266 on Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

RE: Btw, I have not seen an "official announcement" about this customer from the Verséa Ophthalmics LinkedIn page.

This is the basis of my opinion about significant backlogs within the sale channel.

From the July 2023 AXIM Press Release about manufacturing and shipping Diagnostics tests and the five months of silence until the December 20th 2023 Press Release about manufacturing partner Auer Precision I believe there was a growing backlog of sales demand that was not getting filled.

After the Auer Precision announcement or around the same time, we started seeing the #TPOCTITAN announcements on the Verséa Ophthalmics LinkedIn page. About one announcement a week since the first one.

This new customer has not been officially announced yet. Are they "CLIA Certified". I think I have seen a prior post that they are CLIA Certified. But they have not been announced as a #TPOCTITAN.

There may be significant backlogs at every stage of the new customer sales channel.

Just my opinion.
Not investment advice.

[TexasMarvL]

Reread this post and the replies to this post. A second AXIM/Verséa customer replied to the post and mentioned she just completed the Lab Director Certification.

There are self-paced Lab Director courses available online. Here is a link.

https://www.cms.gov/medicare/quality/clinical-laboratory-improvement-amendments/training

Quote:
"The courses listed below are designed to meet the Clinical Laboratory Improvement Amendments (CLIA) requirement at 42 CFR 493.1405(b)(2)(ii)(B)."

This certification might be a requirement before Verséa Ophthalmics sends a person to verify CLIA compliance.

[TexasMarvL]

A Third thing I noticed about this post is that Jessica Barr is not mentioned. This new customer called out "Thank you" to Kerry Robbers and Rahim Hirji. I believe Rahim Hirji has past work experience and his current title of "VP Marketing, Clinical Training and Implementation" would imply that he is qualified to "Approve" that a new customer has met the CLIA standards and requirements and can start selling the new AXIM Diagnostics tests.

If this turns out to be true, then we may see more than one new customer added per week. If Rahim Hirji becomes the second person on the Verséa Ophthalmics staff that is allowed to approve a CLIA compliance certification then time to cashflow positive for AXIM is cut in half.

THREE Takeaways from this post by a new customer:

In my opinion a case can be made that there is a significant backlog of new customers in the process of becomming CLIA Compliant. This eye doctor appears to have taken the steps to become CLIA compliant.

Now we know that Eye Doctors can take an online self-paced course to become CLIA compliant as a Lab Director.

And the third thing we learned from this post is that Jessica Barr might have some help from VP Rahim Hirji to certify a new customer.


Good luck to all.
Not investment advice.